S-Space

Browse

Author

Jump to a point in the index

Or type in a year

Sort by
In order
Results/Page
Authors/record

Showing results 1 to 60 of 101

Issue Date	Title / Author(s) / Citation	File
2002-05	Hepatitis B virus infection and B-cell non-Hodgkin's lymphoma in a hepatitis B endemic area: A case-control study Kim, Jee Hyun; Bang, Yung‐Jue; Park, Byung Joo; Yoo, Taiwoo; Kim, Chul Woo; Kim, Tae‐You; Heo, Dae Seog; Lee, Hyo‐Suk; Kim, Noe Kyeong Japanese Journal of Cancer Research, Vol.93 No.5, pp.471-477	DOI
2003-01	Efficacy of modified regimen with attenuated doses of paclitaxel plus carboplatin combination chemotherapy in elderly and/or weak patients with advanced non-small cell lung cancer Choi, In Sil; Kim, Byung Su; Park, Sook Ryun; Lee, Sang Yoon; Kim, Do Yeun; Kim, Jee Hyun; Lee, Se Hoon; Kim, Tae-You; Heo, Dae Seog; Bang, Yung-Jue; Kim, Noe Kyeong Lung Cancer, Vol.39 No.1, pp.99-101	DOI
2004-11	Neoadjuvant etoposide, ifosfamide, and cisplatin for the treatment of olfactory neuroblastoma Kim, Dong-Wan; Jo, Yo-Han; Kim, Jee Hyun; Wu, Hong-Gyun; Rhee, Chae Seo; Lee, Chol Hee; Kim, Tae You; Heo, Dae Seog; Bang, Yung-Jue; Kim, Noe Kyeong Cancer, Vol.101 No.10, pp.2257-2260	DOI
2005-01	Paclitaxel/platinum-based perioperative chemotherapy and surgery in stage IIIA non-small cell lung cancer Choi, In Sil; Oh, Do-Youn; Kwon, Jung Hye; Kim, Sang-Il; Park, Sook Ryun; Bak, Ji-Youn; Kim, Jee Hyun; Kim, Dong-Wan; Kim, Young Tae; Kim, Tae You; You, Chul-Kyu; Kim, Young Whan; Heo, Dae Seog; Bang, Yung-Jue; Sung, Sook Whan; Park, Charn Il; Kim, Noe Kyeong Japanese Journal of Clinical Oncology, Vol.35 No.1, pp.6-12	DOI
2005-04	Predictive and prognostic impact of epidermal growth factor receptor mutation in non-small-cell lung cancer patients treated with gefitinib Han, Sae-Won; Kim, Tae-You; Hwang, Pil Gyu; Jeong, Soohyun; Kim, Jeongmi; Choi, In Sil; Oh, Do Youn; Kim, Jee Hyun; Kim, Dong-Wan; Chung, Doo Hyun; Im, Seock-Ah; Kim, Young Tae; Lee, Jong Seok; Heo, Dae Seog; Bang, Yung-Jue; Kim, Noe Kyeong Journal of Clinical Oncology, Vol.23 No.11, pp.2493-2501	DOI
2005-10	Reduced dose intensity FOLFOX-4 as first line palliative chemotherapy in elderly patients with advanced colorectal cancer Kim, Jee Hyun; Oh, Do Youn; Kim, Yu Jung; Han, Sae Won; Choi, In-Sil; Kim, Dong Wan; Im, Seock Ah; Kim, Tae You; Lee, Jong Seok; Heo, Dae Seog; Bang, Yung-Jue; Kim, Noe Kyeong Journal of Korean Medical Science, Vol.20 No.5, pp.806-810	DOI
2005-12	Phase II trial of low-dose paclitaxel and cisplatin in patients with advanced gastric cancer Lee, Keun-Wook; Im, Seock Ah; Yun, Tak; Song, Eun Kee; Na, Im Il; Shin, Hyunchoon; Choi, In Sil; Oh, Do Youn; Kim, Jee Hyun; Kim, Dong Wan; Kim, Tae You; Lee, Jong Seok; Heo, Dae Seog; Bang, Yung-Jue; Kim, Noe Kyeong Japanese Journal of Clinical Oncology, Vol.35 No.12, pp.720-726	DOI
2006-04	Optimization of patient selection for gefitinib in non-small cell lung cancer by combined analysis of epidermal growth factor receptor mutation, K-ras mutation, and Akt phosphorylation Han, Sae-Won; Kim, Tae-You; Jeon, Young Kyung; Hwang, Pil Gyu; Im, Seock-Ah; Lee, Kyung-Hun; Kim, Jee Hyun; Kim, Dong-Wan; Heo, Dae-Seog; Kim, Noe Kyeong; Chung, Doo Hyun; Bang, Yung-Jue Clinical Cancer Research, Vol.12 No.8, pp.2538-2544	DOI
2006-09	Antitumor activity of SK-7041, a novel histone deacetylase inhibitor, in human lung and breast cancer cells Lee, Keun-Wook; Kim, Jee Hyun; Park, Jung-Hyun; Kim, Hwang-Phill; Song, Sang-Hyun; Kim, Sang Gyun; Kim, Tai Young; Jong, Hyun-Soon; Jung, Kyung Hae; Im, Seock-Ah; Kim, Tae-You; Kim, Noe Kyeong; Bang, Yung-Jue Anticancer Research, Vol.26 No.5A, pp.3429-3438
2007-06	Artificial nutrition and hydration in terminal cancer patients: the real and the ideal Oh, Do Youn; Kim, Jee Hyun; Lee, Se Hoon; Kim, Dong Wan; Im, Seock-Ah; Kim, Tae You; Heo, Dae Seog; Bang, Yung Jue; Kim, Noe Kyeong Supportive Care in Cancer, Vol.15 No.6, pp.631-636	DOI
2007-09	Phase II study of low-dose paclitaxel and cisplatin as a second-line therapy after 5-fluorouracil/platinum chemotherapy in gastric cancer Lee, Keun-Wook; Kim, Jee Hyun; Yun, Tak; Song, Eun Kee; Na, Im Il; Shin, Hytinchoon; Oh, So Yeon; Choi, In Sil; Oh, Do-Youn; Kim, Dong-Wan; Im, Seock-Ah; Kim, Tae-You; Lee, Jong Seok; Heo, Dae Seog; Bang, Yung-Jue; Kim, Noe Kyeong Journal of Korean Medical Science, Vol.22, pp.S115-S121	view file
2007-11	Prognostic impact of clinicopathologic parameters in stage II/III breast cancer treated with neoadjuvant docetaxel and doxorubicin chemotherapy: paradoxical features of the triple negative breast cancer Keam, Bhumsuk; Im, Seock-Ah; Kim, Hee-Jun; Oh, Do-Youn; Kim, Jee Hyun; Lee, Se-Hoon; Chie, Eui Kyu; Han, Wonshik; Kim, Dong-Wan; Moon, Woo Kyung; Kim, Tae-You; Park, In Ae; Noh, Dong-Young; Heo, Dae Seog; Ha, Sung Whan; Bang, Yung-Jue BMC Cancer, Vol.7, p. 203	view file DOI
2008-05	Modified FOLFOX-6 chemotherapy in advanced gastric cancer: Results of phase II study and comprehensive analysis of polymorphisms as a predictive and prognostic marker Keam, Bhumsuk; Im, Seock-Ah; Han, Sae-Won; Ham, Hye Seon; Kim, Min A.; Oh, Do-Youn; Lee, Se-Hoon; Kim, Jee Hyun; Kim, Dong-Wan; Kim, Tae-You; Heo, Dae Seog; Kim, Woo Ho; Bang, Yung-Jue BMC Cancer, Vol.8, p. 148	view file DOI
2008-06	Gemcitabine and Vinorelbine Combination Chemotherapy in Anthracycline- and Taxane-pretreated Advanced Breast Cancer Kim, Hye Jin; Kim, Jin-Soo; Seo, Myung-Deok; Oh, So-Yeon; Oh, Do Youn; Kim, Jee Hyun; 이세훈; Kim, Dong Wan; Im, Seock Ah; Kim, Tae You; Heo, Dae Seog; Bang, Yung-Jue Cancer Research and Treatment, Vol.40 No.2, pp.81-86
2008-09	Irinotecan combined with 5-fluorouracil and leucovorin as second-line chemotherapy for metastatic or relapsed gastric cancer Seo, Myung-Deok; Lee, Keun-Wook; Lim, Joo Han; Yi, Hyeon Gyu; Kim, Dae-Young; Oh, Do-Youn; Kim, Jee Hyun; Im, Seock-Ah; Kim, Tae-You; Lee, Jong Seok; Bang, Yung-Jue Japanese Journal of Clinical Oncology, Vol.38 No.9, pp.589-595	DOI
2008-10	The clinicopathologic characteristics and prognostic significance of triple-negativity in node-negative breast cancer Rhee, Jiyoung; Han, Sae-Won; Oh, Do-Youn; Kim, Jee Hyun; Im, Seock-Ah; Han, Wonshik; Park, In Ae; Noh, Dong-Young; Bang, Yung-Jue; Kim, Tae-You BMC Cancer, Vol.8, p. 307	view file DOI
2008-12	The growth inhibitory effect of lapatinib, a dual inhibitor of EGFR and HER2 tyrosine kinase, in gastric cancer cell lines Kim, Jin Won; Kim, Hwang-Phill; Im, Seock-Ah; Kang, Soyeong; Hur, Hyung Seok; Yoon, Young-Kwang; Oh, Do-Youn; Kim, Jee Hyun; Lee, Dong Soon; Kim, Tae-You; Bang, Yung-Jue Cancer Letters, Vol.272 No.2, pp.296-306	DOI
2009	Chemotherapy-induced transient CEA and CA19-9 surges in patients with metastatic or recurrent gastric cancer Kim, Hye Jin; Lee, Keun-Wook; Kim, Yu Jung; Oh, Do-youn; Kim, Jee Hyun; Im, Seock-ah; Lee, Jong Seok Acta Oncologica, Vol.48 No.3, pp.385-390	DOI
2009-03	Weight changes after adjuvant treatment in Korean women with early breast cancer Han, Hye-Suk; Lee, Keun-Wook; Kim, Jee Hyun; Kim, Sung-Won; Kim, In-Ah; Oh, Do-Youn; Im, Seock-Ah; Bang, Soo-Mee; Lee, Jong Seok Breast Cancer Research and Treatment, Vol.114 No.1, pp.147-153	DOI
2009-07	Clinical significance of axillary nodal ratio in stage II/III breast cancer treated with neoadjuvant chemotherapy Keam, Bhumsuk; Im, Seock-Ah; Kim, Hee-Jun; Oh, Do-Youn; Kim, Jee Hyun; Lee, Se-Hoon; Chie, Eui Kyu; Han, Wonshik; Kim, Dong-Wan; Cho, Nariya; Moon, Woo Kyung; Kim, Tae-You; Park, In Ae; Noh, Dong-Young; Heo, Dae Seog; Ha, Sung Whan; Bang, Yung-Jue Breast Cancer Research and Treatment, Vol.116 No.1, pp.153-160	DOI
2009-09	Risk factors for poor treatment outcome and central nervous system relapse in diffuse large B-cell lymphoma with bone marrow involvement Lee, Keun-Wook; Yi, Jongyoun; Choi, In Sil; Kim, Jee Hyun; Bang, Soo-Mee; Kim, Dong-Wan; Im, Seock-Ah; Kim, Tae-You; Yoon, Sung-Soo; Lee, Jong Seok; Bang, Yung-Jue; Park, Seonyang; Kim, Byoung Kook; Cho, Han Ik; Heo, Dae Seog Annals of Hematology, Vol.88 No.9, pp.829-838	DOI
2009-10	Weekly Paclitaxel and Trastuzumab as a First-Line Therapy in Patients with HER2-Overexpressing Metastatic Breast Cancer: Magnitude of HER2/neu Amplification as a Predictive Factor for Efficacy Han, Hye-Suk; Kim, Jin-Soo; Park, Jin Hyun; Jeon, Yoon Kyung; Lee, Keun-Wook; Oh, Do-Youn; Kim, Jee Hyun; Park, So Yeon; Im, Seock-Ah; Kim, Tae-You; Park, In Ae; Bang, Yung-Jue Journal of Korean Medical Science, Vol.24 No.5, pp.910-917	view file DOI
2010-02	A multicenter phase II study of gemcitabine and S-1 combination chemotherapy in patients with unresectable pancreatic cancer Oh, Do-Youn; Cha, Yongjun; Choi, In-Sil; Yoon, So-Young; Choi, In Keun; Kim, Jee Hyun; Oh, Sang Cheul; Kim, Chang Duck; Kim, Jae Sun; Bang, Yung-Jue; Kim, Yeul Hong Cancer Chemotherapy and Pharmacology, Vol.65 No.3, pp.527-536	DOI
2010-05	Individualized Tumor Response Testing for Prediction of Response to Paclitaxel and Cisplatin Chemotherapy in Patients with Advanced Gastric Cancer Kim, Jee Hyun; Lee, Keun-Wook; Kim, Yeul Hong; Lee, Kyung Hee; Oh, Do Youn; Kim, Joonhee; Yang, Sung Hyun; Im, Seock-Ah; Choi, Sung Ho; Bang, Yung-Jue Journal of Korean Medical Science, Vol.25 No.5, pp.684-690	DOI
2010-10	Triple negativity and young age as prognostic factors in lymph node-negative invasive ductal carcinoma of 1 cm or less Kwon, Ji Hyun; Kim, Yu Jung; Lee, Keun-Wook; Oh, Do-Youn; Park, So Yeon; Kim, Jee Hyun; Chie, Eui Kyu; Kim, Sung-Won; Im, Seock-Ah; Kim, In-Ah; Kim, Tae-You; Park, In Ae; Noh, Dong-Young; Bang, Yung-Jue; Ha, Sung Whan BMC Cancer, Vol.10, p. 557	view file DOI
2011-03	Ki-67 can be used for further classification of triple negative breast cancer into two subtypes with different response and prognosis Keam, Bhumsuk; Im, Seock-Ah; Lee, Kyung-Hun; Han, Sae-Won; Oh, Do-Youn; Kim, Jee Hyun; Lee, Se-Hoon; Han, Wonshik; Kim, Dong-Wan; Kim, Tae-You; Park, In Ae; Noh, Dong-Young; Heo, Dae Seog; Bang, Yung-Jue Breast Cancer Research, Vol.13 No.2, p. R22	view file DOI
2011-07	Radiotherapy followed by adjuvant temozolomide with or without neoadjuvant ACNU-CDDP chemotherapy in newly diagnosed glioblastomas: a prospective randomized controlled multicenter phase III trial Kim, Il Han; Park, Chul-Kee; Heo, Dae Seog; Kim, Chae-Yong; Rhee, Chang Hun; Nam, Do-Hyun; Lee, Seung Hoon; Han, Jung Ho; Lee, Se-Hoon; Kim, Tae Min; Kim, Dong-Wan; Kim, Jeong Eun; Paek, Sun Ha; Kim, Dong Gyu; Kim, In Ah; Kim, Yu Jung; Kim, Jee Hyun; Park, Byung-Joo; Jung, Hee-Won Journal of Neuro-Oncology, Vol.103 No.3, pp.595-602	DOI
2011-09	Nomogram predicting clinical outcomes in breast cancer patients treated with neoadjuvant chemotherapy Keam, Bhumsuk; Im, Seock-Ah; Park, Sohee; Nam, Byung-Ho; Han, Sae-Won; Oh, Do-Youn; Kim, Jee Hyun; Lee, Se-Hoon; Han, Wonshik; Kim, Dong-Wan; Kim, Tae-You; Park, In Ae; Noh, Dong-Young; Heo, Dae Seog; Bang, Yung-Jue Journal of Cancer Research and Clinical Oncology, Vol.137 No.9, pp.1301-1308	DOI
2011-09	VEGF Expression is Related to Good Response and Long Progression-free Survival in Gastrointestinal Stromal Tumor Patients Treated With Sunitinib Koh, Youngil; Lee, Hee Eun; Im, Seock-Ah; Kim, Se-Hyung; Kim, Tae Min; Han, Sae-Won; Oh, Do-Youn; Kim, Jee Hyun; Lee, Se-Hoon; Kim, Dong-Wan; Kim, Tae-You; Kim, Woo-Ho; Heo, Dae Seog; Bang, Yung-Jue Diagnostic Molecular Pathology, Vol.20 No.3, pp.143-147	DOI
2011-10	Early metabolic response using FDG PET/CT and molecular phenotypes of breast cancer treated with neoadjuvant chemotherapy Keam, Bhumsuk; Im, Seock-Ah; Koh, Youngil; Han, Sae-Won; Oh, Do-Youn; Cho, Nariya; Kim, Jee Hyun; Han, Wonshik; Kang, Keon Wook; Moon, Woo Kyung; Kim, Tae-You; Park, In Ae; Noh, Dong-Young; Chung, June-Key; Bang, Yung-Jue BMC Cancer, Vol.11, p. 452	DOI
2011-11	Preoperative chemoradiation with cetuximab, irinotecan, and capecitabine in patients with locally advanced resectable rectal cancer: A multicenter phase II study Kim, Sun Young; Hong, Yong Sang; Kim, Dae Yong; Kim, Tae Won; Kim, Jee Hyun; Im, Seok Ah; Lee, Keun Seok; Yun, Tak; Jeong, Seung-Yong; Choi, Hyo Seong; Lim, Seok-Byung; Chang, Hee Jin; Jung, Kyung Hae International Journal of Radiation Oncology Biology Physics, Vol.81 No.3, pp.677-683	DOI
2012-01	Clinical outcome of central nervous system metastases from breast cancer: differences in survival depending on systemic treatment Kim, Hee-Jun; Im, Seock-Ah; Keam, Bhumsuk; Kim, Yu-Jung; Han, Sae-Won; Kim, Tae Min; Oh, Do-Youn; Kim, Jee Hyun; Lee, Se-Hoon; Chie, Eui Kyu; Han, Wonshik; Kim, Dong-Wan; Kim, Tae-You; Noh, Dong-Young; Heo, Dae Seog; Park, In Ae; Bang, Yung-Jue; Ha, Sung Whan Journal of Neuro-Oncology, Vol.106 No.2, pp.303-313	DOI
2012-04	Phase II trial of preoperative paclitaxel, gemcitabine, and trastuzumab combination therapy in HER2 positive stage II/III breast cancer: The Korean Cancer Study Group BR 07-01 Im, Seock-Ah; Lee, Keun Seok; Ro, Jungsil; Lee, Eun Sook; Kwon, Youngmee; Ahn, Jin-Hee; Ahn, Jin Seok; Kim, Jee Hyun; Kang, Han Sung; Shin, Kyung Hwan; Noh, Dong-Young; Park, In-Ae; Kim, Sung-Bae; Im, Young Hyuck; Ha, Sung Whan Breast Cancer Research and Treatment, Vol.132 No.2, pp.589-600	DOI
2012-08	ABCB1, FCGR2A, and FCGR3A Polymorphisms in Patients with HER2-Positive Metastatic Breast Cancer Who Were Treated with First-Line Taxane plus Trastuzumab Chemotherapy Kim, Ji-Won; Kim, Jee Hyun; Im, Seock-Ah; Kim, Yu Jung; Han, Hye-Suk; Kim, Jin-Soo; Han, Sae-Won; Jeon, Yoon Kyung; Oh, Do-Youn; Han, Wonshik; Kim, Tae-You; Park, In Ae; Noh, Dong-Young; Bang, Yung-Jue Oncology, Vol.83 No.4, pp.218-227	DOI
2012-09	Phase II clinical trial of induction chemotherapy with fixed dose rate gemcitabine and cisplatin followed by concurrent chemoradiotherapy with capecitabine for locally advanced pancreatic cancer Kim, Jae-Sung; Lim, Joo Han; Kim, Jee Hyun; Im, Seock-Ah; Chie, Eui Kyu; Hwang, Jin-Hyeok; Kim, Tae-You; Bang, Yung-Jue; Ha, Sung Whan; Yoon, Yong Bum Cancer Chemotherapy and Pharmacology, Vol.70 No.3, pp.381-389	DOI
2012-11	The Lack of CD34 Expression in Gastrointestinal Stromal Tumors is Related to Cystic Degeneration Following Imatinib Use Koh, Youngil; Lee, Hee Eun; Oh, Do-Youn; Kim, Jee Hyun; Lee, Se-Hoon; Kim, Se Hyung; Kim, Dong-Wan; Im, Seock-Ah; Kim, Tae-You; Heo, Dae Seog; Kim, Woo-Ho; Bang, Yung-Jue Japanese Journal of Clinical Oncology, Vol.42 No.11, pp.1020-1027	DOI
2012-12	Body Mass Index Is Not Associated with Treatment Outcomes of Breast Cancer Patients Receiving Neoadjuvant Chemotherapy: Korean Data Lee, Kytmg-Hun; Keam, Bhumsuk; Im, Seock-Ah; Kim, Tae-Yong; Han, Sae-Won; Oh, Do-Youn; Kim, Jee Hyun; Lee, Se-Hoon; Han, Wonshik; Kim, Dong-Wan; Kim, Tae-You; Park, In Ae; Noh, Dong-Young; Heo, Dae Seog; Bang, Yung-Jue Journal of Breast Cancer, Vol.15 No.4, pp.427-433	view file DOI
2013-01	KRAS mutation status and clinical outcome of preoperative chemoradiation with cetuximab in locally advanced rectal cancer: A pooled analysis of 2 phase II trials Kim, Sun Young; Shim, Eun Kyung; Yeo, Hyun Yang; Baek, Ji Yeon; Hong, Yong Sang; Kim, Dae Yong; Kim, Tae Won; Kim, Jee Hyun; Im, Seock-Ah; Jung, Kyung Hae; Chang, Hee Jin International Journal of Radiation Oncology Biology Physics, Vol.85 No.1, pp.201-207	DOI
2013-04	Pharmacogenetic analysis of adjuvant FOLFOX for Korean patients with colon cancer Lee, Kyung-Hun; Chang, Hye Jung; Han, Sae-Won; Oh, Do-Youn; Im, Seock-Ah; Bang, Yung-Jue; Kim, Sun Young; Lee, Keun-Wook; Kim, Jee Hyun; Hong, Yong Sang; Kim, Tae Won; Park, Young Suk; Kang, Won Ki; Shin, Sang Joon; Ahn, Joong Bae; Kang, Gyeong Hoon; Jeong, Seung-Yong; Park, Kyu Joo; Park, Jae-Gahb; Kim, Tae-You Cancer Chemotherapy and Pharmacology, Vol.71 No.4, pp.843-851	DOI
2013-04	Predictive value of FDG PET/CT for pathologic axillary node involvement after neoadjuvant chemotherapy Keam, Bhumsuk; Im, Seock-Ah; Koh, Youngil; Han, Sae-Won; Oh, Do-Youn; Cho, Nariya; Kim, Jee Hyun; Han, Wonshik; Kang, Keon Wook; Moon, Woo Kyung; Kim, Tae-You; Park, In Ae; Noh, Dong-Young; Chung, June-Key; Bang, Yung-Jue Breast Cancer, Vol.20 No.2, pp.167-173	DOI
2013-05	Phase III, Multicenter, Randomized Trial of Maintenance Chemotherapy Versus Observation in Patients With Metastatic Breast Cancer After Achieving Disease Control With Six Cycles of Gemcitabine Plus Paclitaxel As First-Line Chemotherapy: KCSG-BR07-02 Park, Yeon Hee; Jung, Kyung Hae; Im, Seock-Ah; Sohn, Joo Hyuk; Ro, Jungsil; Ahn, Jin-Hee; Kim, Sung-Bae; Nam, Byung-Ho; Oh, Do Youn; Han, Sae-Won; Lee, Soohyeon; Park, In Hae; Lee, Keun Seok; Kim, Jee Hyun; Kang, Seok Yun; Lee, Moon Hee; Park, Hee Sook; Ahn, Jin Seok; Im, Young-Hyuck Journal of Clinical Oncology, Vol.31 No.14, pp.1732-+	DOI
2013-07	HER2/CEP17 ratio and HER2 immunohistochemistry predict clinical outcome after first-line trastuzumab plus taxane chemotherapy in patients with HER2 fluorescence in situ hybridization-positive metastatic breast cancer Kim, Ji-Won; Kim, Jee Hyun; Im, Seock-Ah; Kim, Yu Jung; Han, Hye-Suk; Kim, Jin-Soo; Lee, Kyung-Hun; Kim, Tae-Yong; Han, Sae-Won; Jeon, Yoon Kyung; Oh, Do-Youn; Kim, Tae-You; Park, In Ae Cancer Chemotherapy and Pharmacology, Vol.72 No.1, pp.109-115	DOI
2013-10	Irinotecan combined with 5-fluorouracil and leucovorin third-line chemotherapy after failure of fluoropyrimidine, platinum, and taxane in gastric cancer: treatment outcomes and a prognostic model to predict survival Kang, Eun Joo; Im, Seock-Ah; Oh, Do-Youn; Han, Sae-Won; Kim, Jin-Soo; Choi, In Sil; Kim, Jin Won; Kim, Yu Jung; Kim, Jee Hyun; Kim, Tae-You; Lee, Jong Seok; Bang, Yung-Jue; Lee, Keun-Wook Gastric Cancer, Vol.16 No.4, pp.581-589	DOI
2013-11	Serum epidermal growth factor is associated with prognosis and hormone receptor status in patients with HER2-positive metastatic breast cancer treated with first-line trastuzumab plus taxane chemotherapy Kim, Ji-Won; Kim, Jee Hyun; Im, Seock-Ah; Lee, Kyung-Hun; Kim, Jin-Soo; Kim, Tae-Yong; Han, Sae-Won; Jeon, Yoon Kyung; Oh, Do-Youn; Kim, Tae-You; Park, In Ae Cancer Chemotherapy and Pharmacology, Vol.72 No.5, pp.1023-1029	DOI
2014-02	A Phase II Study of Bevacizumab, Oxaliplatin, and Capecitabine in Patients With Previously Untreated Metastatic Colorectal Cancer A Prospective, Multicenter Trial of the Korean Cancer Study Group Hong, Yong Sang; Lee, Sung Sook; Kim, Kyu-pyo; Lee, Jae-Lyun; Kang, Yoon-Koo; Shin, Sang Joon; Ahn, Joong Bae; Jung, Kyung Hae; Im, Seock-Ah; Kim, Tae-You; Kim, Jee Hyun; Park, Young Suk; Kim, Tae Won American Journal of Clinical Oncology, Vol.37 No.1, pp.19-23	DOI
2014-07	Lamivudine prophylaxis for hepatitis B virus carrier patients with breast cancer during adjuvant chemotherapy Lee, Hyun Jung; Kim, Dae Young; Keam, Bhumsuk; Lee, Jeong Hoon; Han, Sae-Won; Oh, Do-Youn; Yoon, Jung Hwan; Kim, Tae-You; Kim, Yu Jung; Lee, Keun Wook; Kim, Jin-Wook; Jeong, Sook-Hyang; Lee, Jong Seok; Kim, Jee Hyun; Im, Seock-Ah Breast Cancer, Vol.21 No.4, pp.387-393	DOI
2014-08	Combination of docetaxel and TSU-68, an oral antiangiogenic agent, in patients with metastatic breast cancer previously treated with anthracycline: Randomized phase II multicenter trial Kim, Sung-Bae; Yoo, Changhoon; Ro, Jungsil; Im, Seock-Ah; Im, Young-Hyuck; Kim, Jee Hyun; Ahn, Jin-Hee; Jung, Kyung Hae; Song, Hong Suk; Kang, Seok Yun; Park, Hee Sook; Chung, Hyun-Cheol Investigational New Drugs, Vol.32 No.4, pp.753-761	DOI
2014-08	Single-Nucleotide Polymorphisms in the Vascular Endothelial Growth Factor Pathway and Outcomes of Patients Treated with First-Line Cytotoxic Chemotherapy Combined with Bevacizumab for Advanced Colorectal Cancer Sohn, Byeong Seok; Park, Seong Joon; Kim, Jeong Eun; Kim, Kyu-pyo; Hong, Yong Sang; Suh, Cheolwon; Kim, Yong Sung; Kim, Seon Young; Im, Seock-Ah; Kim, Sun Young; Kim, Jee Hyun; Ahn, Joong Bae; Park, Young Suk; Kim, Tae Won Oncology, Vol.87 No.5, pp.280-292	DOI
2014-09	Prediction of survival in terminally ill cancer patients at the time of terminal cancer diagnosis Kim, Yu Jung; Kim, Su-Jung; Lee, June Koo; Choi, Won-Suk; Park, Jin Hyun; Kim, Hee Jun; Sim, Sung Hoon; Lee, Keun-Wook; Lee, Se-Hoon; Kim, Jee Hyun; Kim, Dong-Wan; Lee, Jong Seok; Bang, Yung-Jue; Heo, Dae Seog Journal of Cancer Research and Clinical Oncology, Vol.140 No.9, pp.1567-1574	DOI
2014-09	Phase II trial of gemcitabine plus UFT as salvage treatment in oxaliplatin, irinotecan and fluoropyrimidine-refractory metastatic colorectal cancer Lee, Keun-Wook; Kim, Yu Jung; Lee, Kyung-Hun; Han, Sae-Won; Kim, Tae-Yong; Oh, Do-Youn; Im, Seock-Ah; Kim, Tae-You; Bang, Yung-Jue; Choi, In Sil; Kim, Jee Hyun Cancer Chemotherapy and Pharmacology, Vol.74 No.3, pp.447-455	DOI
2014-12	HER2 Heterogeneity Affects Trastuzumab Responses and Survival in Patients With HER2-Positive Metastatic Breast Cancer Lee, Hee Jin; Seo, An Na; Kim, Eun Joo; Jang, Min Hye; Suh, Koung Jin; Ryu, Han Suk; Kim, Yu Jung; Kim, Jee Hyun; Im, Seock-Ah; Gong, Gyungyub; Jung, Kyung Hae; Park, In Ae; Park, So Yeon American Journal of Clinical Pathology, Vol.142 No.6, pp.755-766	DOI
2015-01	ABCB1 polymorphism as prognostic factor in breast cancer patients treated with docetaxel and doxorubicin neoadjuvant chemotherapy Kim, Hee-Jun; Im, Seock-Ah; Keam, Bhumsuk; Ham, Hye Seon; Lee, Kyung Hun; Kim, Tae Yong; Kim, Yu Jung; Oh, Do-Youn; Kim, Jee Hyun; Han, Wonshik; Jang, In-Jin; Kim, Tae-You; Park, In Ae; Noh, Dong Young Cancer Science, Vol.106 No.1, pp.86-93	DOI
2015-06	A phase I/II trial of second-line chemotherapy with paclitaxel and irinotecan in fluoropyrimidine- and platinum-pretreated patients with advanced gastric cancer Kim, Jin Won; Choi, In Sil; Kim, Yu Jung; Lee, Kyung-Hun; Lee, Keun-Wook; Kim, Tae-Yong; Han, Sae-Won; Kim, Jee Hyun; Kim, Tae-You; Lee, Jong Seok; Bang, Yung-Jue; Im, Seock-Ah; Oh, Do-Youn Cancer Chemotherapy and Pharmacology, Vol.75 No.6, pp.1175-1182	DOI
2015-07	Quality of life (QoL) in metastatic breast cancer patients with maintenance paclitaxel plus gemcitabine (PG) chemotherapy: results from phase III, multicenter, randomized trial of maintenance chemotherapy versus observation (KCSG-BR07-02) Park, Yeon Hee; Jung, Kyung Hae; Im, Seock-Ah; Sohn, Joo Hyuk; Ro, Jungsil; Ahn, Jin-Hee; Kim, Sung-Bae; Nam, Byung-Ho; Oh, Do Youn; Han, Sae-Won; Lee, Soohyeon; Park, In Hae; Lee, Keun Seok; Kim, Jee Hyun; Kang, Seok Yun; Lee, Moon Hee; Park, Hee Sook; Woo, Sook Young; Jung, Sin-Ho; Ahn, Jin Seok; Im, Young-Hyuck Breast Cancer Research and Treatment, Vol.152 No.1, pp.77-85	DOI
2016-01	Phase I study of CKD-516, a novel vascular disrupting agent, in patients with advanced solid tumors Oh, Do-Youn; Kim, Tae-Min; Han, Sae-Won; Shin, Dong-Yeop; Lee, Yun Gyoo; Lee, Keun-Wook; Kim, Jee Hyun; Kim, Tae-You; Jang, In-Jin; Lee, Jong-Seok; Bang, Yung-Jue Cancer Research and Treatment, Vol.48 No.1, pp.28-36	DOI
2016-01	Amphiregulin confers trastuzumab resistance via AKT and ERK activation in HER2-positive breast cancer Kim, Ji-Won; Kim, Debora K.; Min, Ahrum; Lee, Kyung-Hun; Nam, Hyun-Jin; Kim, Jee Hyun; Kim, Jin-Soo; Kim, Tae-Yong; Im, Seock-Ah; Park, In Ae Journal of Cancer Research and Clinical Oncology, Vol.142 No.1, pp.157-165	DOI
2016-04	A randomized, multicenter, phase II/III study to determine the optimal dose and to evaluate the efficacy and safety of pegteograstim (GCPGC) on chemotherapy-induced neutropenia compared to pegfilgrastim in breast cancer patients: KCSG PC10-09 Lee, Ki Hyeong; Kim, Ji-Yeon; Lee, Moon Hee; Han, Hye Sook; Lim, Joo Han; Park, Keon Uk; Park, In Hae; Cho, Eun Kyung; Yoon, So Young; Kim, Jee Hyun; Choi, In Sil; Park, Jae Hoo; Choi, Young Jin; Kim, Hee-Jun; Jung, Kyung Hae; Kim, Si-Young; Oh, Do-Youn; Im, Seock-Ah Supportive Care in Cancer, Vol.24 No.4, pp.1709-1717	DOI
2016-04	Circulating plasma biomarkers for TSU-68, an oral antiangiogenic agent, in patients with metastatic breast cancer Yoo, Changhoon; Kim, Sung-Bae; Ro, Jungsil; Im, Seock-Ah; Im, Young-Hyuck; Kim, Jee Hyun; Ahn, Jin-Hee; Jung, Kyung Hae; Song, Hong Suk; Kang, Seok Yun; Park, Hee Sook; Chung, Hyun-Cheol Cancer Research and Treatment, Vol.48 No.2, pp.499-507	DOI
2016-05	Expression of breast cancer stem cell markers as predictors of prognosis and response to trastuzumab in HER2-positive breast cancer Seo, An Na; Lee, Hee Jin; Kim, Eun Joo; Jang, Min Hye; Kim, Yu Jung; Kim, Jee Hyun; Kim, Sung-Won; Ryu, Han Suk; Park, In Ae; Im, Seock-Ah; Gong, Gyungyub; Jung, Kyung Hae; Kim, Hee Jeong; Park, So Yeon British Journal of Cancer, Vol.114 No.10, pp.1109-1116	DOI
2016-10	Prognostic value of axillary nodal ratio after neoadjuvant chemotherapy of doxorubicin/cyclophosphamide followed by docetaxel in breast cancer: A multicenter retrospective cohort study Kim, Se Hyun; Jung, Kyung Hae; Kim, Tae-Yong; Im, Seock-Ah; Choi, In Sil; Chae, Yee Soo; Baek, Sun Kyung; Kang, Seok Yun; Park, Sarah; Park, In Hae; Lee, Keun Seok; Choi, Yoon Ji; Lee, Soohyeon; Sohn, Joo Hyuk; Park, Yeon-Hee; Im, Young-Hyuck; Ahn, Jin-Hee; Kim, Sung-Bae; Kim, Jee Hyun Cancer Research and Treatment, Vol.48 No.4, pp.1373-1381	DOI

1 2